Campbell's Beats Earnings Estimates; Eli Lilly Obesity Drug Data Boosts Shares; Marvell and Flex to Join S&P 500
Campbell's Company reported adjusted Q3 earnings per share above analyst expectations, while Eli Lilly shares rose following obesity drug presentations at the American Diabetes Association conference. Marvell Technology and Flex are set to replace Pool Corp. and Campbell's in the S&P 500 on June 22. The index changes signal a broader shift in market composition, reflecting growing investor interest in technology and healthcare sectors.
Campbell's Company saw its shares edge higher in premarket trading after posting adjusted Q3 earnings per share that exceeded the average analyst estimate. Eli Lilly shares also gained following presentations of its obesity drug data at the American Diabetes Association conference, with Citi analysts reaffirming their conviction in the stock, citing the company's diversified incretin portfolio rather than reliance on a single blockbuster drug. Meanwhile, Marvell Technology and Flex are set to be added to the S&P 500 index on June 22, replacing Pool Corp. and Campbell's, according to S&P Dow Jones Indices. The index reshuffling reflects ongoing changes in the composition of large-cap U.S. equities, with technology firms gaining prominence. Campbell's removal from the S&P 500 coincides with its earnings beat, underscoring the mixed signals facing the legacy consumer staples company.
What's missing
The specific details of Eli Lilly's obesity drug trial results presented at the ADA conference are not described, nor is there context on why Campbell's is being removed from the S&P 500 despite its earnings beat.
How coverage differed
Only one source was provided, Bloomberg, which presented the story in a straightforward, market-focused manner without notable ideological framing. No contrasting perspectives from other outlets are available for comparison.
What different sources said
- BloombergCenter
Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers
Related
China's Exports to US Surge 35% in May, Defying Trump's Tariff Expectations
China's exports to the United States jumped more than 35% year-over-year in May 2025, the strongest pace since early 2021, driven by technology, semiconductors, and electric vehicles. The surge follows Trump's return to office and implementation of tariffs in April, which had initially caused sharp declines in Chinese shipments. The rebound suggests China's export-dependent economy is adapting to trade tensions while benefiting from global demand for AI and green technology products.
Boeing Increases Aircraft Deliveries, Signaling Production Recovery
Boeing has reported another increase in aircraft deliveries, demonstrating continued progress in ramping up production. The aerospace manufacturer has been working to recover from previous quality control issues and supply chain disruptions. The delivery numbers are significant for Boeing's financial recovery and investor confidence in the company's turnaround efforts.
CD Account Interest Rates and Earnings for $200,000 Deposits
CBS News published a financial guide explaining how much interest a $200,000 certificate of deposit (CD) account can earn at current rates, with examples ranging from $1,922 for a 3-month CD to $16,986 for a 2-year CD. The article positions CDs as a safer alternative to stock investments amid market volatility and economic uncertainty. The guidance is relevant for savers seeking to protect retirement funds while earning guaranteed returns in the current interest rate environment.